← Back to Intel
Insider ActivityMNPR
Robinson Chandler, Chief Executive Officer, Director at Monopar Therapeutics, traded $108K of MNPR
Updated Jun 11, 2026
Robinson Chandler
Chief Executive Officer, Director
Monopar Therapeutics ·
$MNPR
Transaction Details
| Insider | Robinson Chandler |
|---|---|
| Title | Chief Executive Officer, Director |
| Company | Monopar Therapeutics |
| Ticker | MNPR |
| Transaction Type | Tax |
| Transaction Date | 2026-03-31 |
| Shares Traded | 1,972 |
| Price Per Share | $54.79 |
| Total Value | $108K |
| Filed Date | 2026-04-02 |
| Accession Number | 0001437749-26-011079 |
Ownership Context
| Shares Owned After Transaction | 90,478 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001437749-26-011079
Other Insider Trades — MNPR
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Robinson Chandler | Chief Executive Officer, Director | traded | — | 2026-03-31 |
| Cittadine Andrew | Chief Operating Officer | traded | — | 2026-03-31 |
| Cittadine Andrew | Chief Operating Officer | traded | $86K | 2026-03-31 |
Other Trades by Robinson Chandler
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| MNPR | Monopar Therapeutics | traded | — | 2026-03-31 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MNPR — Monopar Therapeutics →
Track MNPR insider activity in real time on The Wire →
Get alerts when Robinson Chandler files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 11, 2026 at 07:22 UTC